ＥＧＦＲ変異を有する非小細胞肺がんの治療

Title:

ＥＧＦＲ変異を有する非小細胞肺がんの治療

Document Type and Number:

Japanese Patent JP2023539589

Kind Code:

A

Abstract:

本発明は、ＥＧＦＲエクソン２０挿入及び他のまれなＥＧＦＲ変異を有する対象の治療に関する。

More Like This:

JPH09235297	IMMUNOGEN OR VACCINE CONTAINING ANTIGENIC HIV-I AMINO ACID SEQUENCE
WO/2020/038355	USE OF TIM-3 ANTIBODY IN PREPARATION OF MEDICINES FOR TREATING TUMORS
WO2000020589	PTANs: TESTIS SPECIFIC PROTEINS EXPRESSED IN PROSTATE CANCER

Inventors:

Knobloch, Roland
Moores, Sheri

Application Number:

JP2023513309A

Publication Date:

September 15, 2023

Filing Date:

August 25, 2021

Export Citation:

Assignee:

Janssen Biotech, Incorporated

International Classes:

A61K39/395; A61K31/506; A61K31/517; A61K31/5377; A61K45/00; A61P35/00; G01N33/50; G01N33/68

Attorney, Agent or Firm:

Hiroshi Kobayashi
Eiji Katayama
Junko Kobayashi
Norio Omori
Ryo Hoshikawa

Previous Patent: Use of mitoxantrone hydrochloride liposomes and cyclophosphamide, vincristine, and prednisone

Next Patent: therapeutic agent for inhalation